Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Construct Validity of the Four Square Step Test in Multiple Sclerosis.
Effect of Alfacalcidol on multiple sclerosis-related fatigue: A randomized, double-blind placebo-controlled study.
Boosting CNS axon regeneration by circumventing limitations of natural cytokine signaling.
Multiple sclerosis: Bigger brains resist disability in MS.
Sodium intake is associated with increased disease activity in multiple sclerosis.
The Keap1-Nrf2-ARE Pathway As a Potential Preventive and Therapeutic Target: An Update.
Leptin and other adipokines in EAE and MS
Quantitative Susceptibility Mapping Indicates a Disturbed Brain Iron Homeostasis in Neuromyelitis Optica - A Pilot Study.
Moody microbes or fecal phrenology: what do we know about the microbiota-gut-brain axis?
Analysis of Expenditure in Multiple Sclerosis Disease Modifying Therapies Evolution Between 2004-2013 in Spain.
Factors Associated with Caregiver's Burden in Relapsing-Remitting Multiple Sclerosis and Satisfaction with Current Therapies. MS-Feeling Study.
[The biological role of sulfatides].
Static posturography across the EDSS scale in people with multiple sclerosis: a cross sectional study.
All relapsing multiple sclerosis patients should be seen in specialist clinics - NO.
Glial progenitor cell-based treatment of the childhood leukodystrophies.
Gut environment-induced intraepithelial autoreactive CD4(+) T cells suppress central nervous system autoimmunity via LAG-3.
The Rao's Brief Repeatable Battery in the study of cognition in different multiple sclerosis phenotypes: application of normative data in a Serbian population.
MicroRNAs targeting TGFβ signalling underlie the regulatory T cell defect in multiple sclerosis.
Cost-Utility Analysis (cua) Of First-Line Disease-Modifying Treatments (DMT) Versus Best Supportive Care (Bsc) In Finnish Relapsing-Remitting Multiple Sclerosis (RRMS) Patients.
Novel Insights into the Multiple Sclerosis Risk Gene ANKRD55.
Evaluation of quality of life in individuals with severe chronic motor disability: A major challenge.
Efficacy of hematopoietic stem cell formultiple sclerosis, an evidence based meta-analysis.
Co-occurrence of multiple sclerosis and Parkinson disease.
Development of a primary cutaneous CD30(+) anaplastic large-cell T-cell lymphoma during treatment of multiple sclerosis with fingolimod.
Understanding walking activity in multiple sclerosis: step count, walking intensity and uninterrupted walking activity duration related to degree of disability.

Pages